Core Scientific Inc (CORZ) financials
Core Scientific revenue and earnings by year
Core Scientific's revenue was $319 million in the fiscal year to December 31, 2025, down 37.5% from the year before. Net income was -$289 million, -90.5% of revenue. Since the fiscal year to December 31, 2020, revenue has grown 39.5% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 6 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Revenue | 0.32 | 0.51 | 0.50 | 0.64 | 0.54 | 0.06 |
| Revenue growth | -37.5% | 1.6% | -21.5% | 17.6% | 802.7% | — |
| Gross profit | 0.04 | 0.12 | 0.12 | 0.01 | 0.24 | 0.01 |
| Gross margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% |
| Operating income | -0.25 | -0.14 | 0.01 | -2.11 | 0.13 | -0.01 |
| Operating margin | -77.0% | -27.8% | 1.8% | -329.5% | 24.2% | -10.5% |
| Net income | -0.29 | -1.44 | -0.25 | -2.15 | 0.05 | -0.01 |
| Net margin | -90.5% | -281.6% | -49.1% | -335.2% | 8.7% | -20.2% |
| Diluted EPS | -$0.88 | -$6.13 | -$0.65 | -$6.30 | $0.20 | — |
| Free cash flow | -0.45 | -0.05 | 0.05 | -0.40 | -0.06 | -0.03 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CORZ in Markets.
See also: CORZ returns
No forecast, no recommendation. This page describes Core Scientific Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.